Design and Evaluation of a Nanotechnology-Based Drug Delivery System for Enhanced Efficacy and Safety in Cancer Treatment

A cancer treatment drug delivery system based on nanotechnology has been created and tested. Characterization, formulation, and optimization of a nanoscale drug delivery system were the objectives. The effectiveness and safety of the system were evaluated using cancer cell lines and animal models. The findings demonstrate how pharmaceutical delivery systems based on nanotechnology can enhance cancer therapy outcomes while minimizing toxicity. Numerous studies have shown that nanotechnology-based drug delivery systems can successfully treat cancer. While gold nanoparticles carry anti-cancer medications, liposome-based medication delivery techniques inhibit the proliferation of breast cancer cells. This discovery will probably enhance cancer treatment by lowering side effects and enhancing results. The research might result in improved cancer therapies and patient outcomes. Targeted drug delivery utilizing nanoscale particles may increase the effectiveness and security of cancer treatment. Systems for delivering medications based on nanotechnology can help patients with cancer receive better care.